tradingkey.logo
tradingkey.logo

Medicus Pharma Announces Skinject® Phase 2 Principal Investigator And Key Opinion Leader (Kol), Babar K. Rao MD, Faad, To Provide Clinical Interpretation Of Positive Data During Business Update Webcast On March 26

ReutersMar 16, 2026 11:38 AM

- Medicus Pharma Ltd MDCX.O:

  • MEDICUS PHARMA ANNOUNCES SKINJECT® PHASE 2 PRINCIPAL INVESTIGATOR AND KEY OPINION LEADER (KOL), BABAR K. RAO MD, FAAD, TO PROVIDE CLINICAL INTERPRETATION OF POSITIVE DATA DURING BUSINESS UPDATE WEBCAST ON MARCH 26

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI